AI Verdict
LGNZZ has stronger fundamentals based on our AI analysis.
LGNZZ vs LGN Fundamental Comparison
| Metric | LGNZZ | LGN |
|---|---|---|
| Revenue | $268.1M | $2.6B |
| Net Income | $124.5M | $-59.8M |
| Net Margin | 46.4% | -2.3% |
| ROE | 12.2% | -15.2% |
| ROA | 8.0% | -2.2% |
| Current Ratio | 22.23x | 1.57x |
| Debt/Equity | 0.03x | 2.10x |
| EPS | $6.13 | $-0.57 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LGNZZ vs LGN: Frequently Asked Questions
Is LGNZZ or LGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LGNZZ has stronger fundamentals. LGNZZ is rated BUY (75% confidence) while LGN is rated SELL (72% confidence). This is not investment advice.
How does LGNZZ compare to LGN fundamentally?
LIGAND PHARMACEUTICALS INC has ROE of 12.2% vs Legence Corp.'s -15.2%. Net margins are 46.4% vs -2.3% respectively.
Which stock pays higher dividends, LGNZZ or LGN?
LGNZZ has a dividend yield of N/A or no dividend while LGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LGNZZ or LGN for long term?
For long-term investing, consider that LGNZZ has BUY rating with 75% confidence, while LGN has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LGNZZ vs LGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LGNZZ vs LGN, the AI consensus favors LGNZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.